Pierre-Yves Oehrli, Author at Greater Geneva Bern area - Page 10 of 57

Data protection Impressum

TheraMe!, a Lausanne-based medtech, is transforming cancer treatment by partnering with CSEM to develop an automated, microfluidic-based instrument. This breakthrough technology enables personalized drug screening on live tumor samples, providing cancer patients with tailored therapy recommendations before treatment begins.

CSEM and TheraMe! transform cancer therapy with personalized drug screening technology

28 January 2025

Geneva-based Transmutex has been awarded USD 4.2 million from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) as part of the NEWTON program. The funding will support a project at Los Alamos to develop technologies that transform long-lived radioactive waste into shorter-lived isotopes, addressing a critical challenge in nuclear waste management.

Transmutex secures USD 4.2 million for the transmutation of nuclear waste

27 January 2025

Fribourg-based company Builtronics is making strides in autonomous and remotely operated machinery, targeting the agriculture and construction industries. With significant support from local institutions, the company’s cutting-edge technology is paving the way for safer and more efficient solutions.

Fribourg’s Builtronics pioneers autonomous solutions in agriculture and construction

27 January 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

EBAMed has secured an additional EUR 1.6 million in Series A funding, bringing the total raised to EUR 16 million. This new investment, contributed by CDP Venture Capital and the European Union, supports the development of EBAMed’s groundbreaking CardioKit system for non-invasive treatment of heart arrhythmias using Proton Therapy.

Geneva medtech EBAMed completes financing round with EUR 16 million

27 January 2025

SolidWatts has raised EUR 850,000 in a pre-seed funding round led by Evercurious VC, with participation from Switzerland’s Kickfund, COREangels Climate, and prominent angel investors. The funds will accelerate the development of its clean industrial heating solutions and expand its market presence.

SolidWatts secures funds to transform traditional industrial heating

22 January 2025

CSEM, in collaboration with Thales Alenia Space and Lisi Aerospace Additive Manufacturing, has created an innovative 3D-printed pipe segment for advanced thermal management systems in satellites.

CSEM develops a 3D-printed thermal control system for satellites

22 January 2025

Geneva-based BrainScape Medical, a newly incorporated company specializing in neuromonitoring and neurostimulation technologies, has announced several milestones, including new leadership, FDA Breakthrough Device Designation, and promising results from its first human trials.

BrainScape Medical makes strides in long-term brain monitoring

21 January 2025

Geneva-based Cerret has launched its discreet safety bracelet, merging luxury design with advanced emergency technology. Global demand is growing rapidly, with over 150 units already shipped worldwide and 400 pre-orders in progress.

Geneva’s Cerret rethinks safety with its innovative luxury bracelet

21 January 2025

Glueckkanja AG, a leading provider of Microsoft-based cloud solutions, has officially established a presence in Bern. Facilitated by the Greater Geneva Bern area (GGBa) and the Bern Economic Development Agency, the company’s Swiss subsidiary is now registered and ready to serve local businesses.

German IT specialist Glueckkanja establishes a presence in the canton of Bern

21 January 2025

1 … 6 7 8 9 10 11 12 13 14 … 57